Tag Archives: SMPQY

Top 10 Undervalued Stocks To Watch Right Now

On September 26, USG Corporation (NYSE:USG) shareholders voted to approve the company’s acquisition by a private German business, and although this transaction is not complete yet, a review of this holding seems appropriate. We began purchasing USG shares for the Fund in May 2015, believing that the company’s position in wallboard and structural ceiling tile was undervalued. We spent five months gradually building the position in the portfolio to an appropriate size. The stock was volatile over the next three years as the company’s earnings stream proved to be rather inconsistent. We stuck with the holding, however, with occasional sales to fund more pressing demands on the portfolio’s cash. In early 2018, the share price rose to the $40 level, which approached our sell target. We began cutting back the holding to fund more attractive opportunities. In June, the company agreed to be acquired for $43.50 in cash, and we sold more shares both to reduce the Fund’s exposure to the risk of the deal breaking and because the spread between the deal price and the market price was less rewarding than for other securities we were considering. Assuming completion of this transaction early next year, USG overall will have generated a compound annualized return in the mid-teens for the Fund—not heroic, but a solid example of our identifying an issue selling for materially less than an investor would pay to own it in its entirety. We thank the USG management team for their excellent work for the Fund’s shareholders.

Top 10 Undervalued Stocks To Watch Right Now: AXT Inc(AXTI)

Advisors’ Opinion:

  • [By Logan Wallace]

    Texas Instruments (NASDAQ: TXN) and AXT (NASDAQ:AXTI) are both computer and technology companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, valuation, dividends and risk.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on AXT (AXTI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin] Gainers
    Comstock Holding Companies, Inc. (NASDAQ: CHCI) shares surged 115.8 percent to $4.3591. Comstock reported conversion of the majority of its unsecured, short-term debt into non-convertible preferred equity.
    Stellar Biotechnologies, Inc. (NASDAQ: SBOT) jumped 38.2 percent to $3.0251 after the company disclosed that it achieved robust viral clearance for its manufacturing process.
    Universal Corporation (NYSE: UVV) surged 26.7 percent to $61.40 after reporting fiscal Q4 results.
    Hudson Technologies Inc. (NASDAQ: HDSN) rose 18.9 percent to $2.58.
    Evolus, Inc. (NASDAQ: EOLS) shares gained 17.8 percent to $22.8009.
    The Cato Corporation (NYSE: CATO) shares gained 17.5 percent to $21.07 after the company posted better-than-expected first-quarter results.
    Tyme Technologies, Inc. (NASDAQ: TYME) rose 15.9 percent to $3.3613.
    Destination Maternity Corporation (NASDAQ: DEST) shares gained 15.5 percent to $3.35 after the board announced late Wednesday the election of four activist-backed director nominees. Three women and one man comprise the selected group championed by NGM Capital’s Nathan Miller and Kenosis Capital’s Peter O’Malley. Destination Maternity had advocated for another slate of three men and interim CEO Melissa Payner-Gregor. The new directors are Holly Alden, Marla Ryan, Anne-Charlotte Windal and Christopher Morgan.
    AXT, Inc. (NASDAQ: AXTI) rose 15 percent to $7.65.
    nLIGHT, Inc. (NASDAQ: LASR) gained 14.5 percent to $34.27 following Q1 results.
    Achieve Life Sciences, Inc. (NASDAQ: ACHV) rose 14.3 percent to $11.4303.
    Bilibili Inc.. (NASDAQ: BILI) shares climbed 13.9 percent to $14.16 after announcing Q1 results.
    Babcock & Wilcox Enterprises, Inc. (NYSE: BW) gained 13.2 percent to $2.91 after an amended 13D filing from Steel Partners Holdings shows a raised stake in the company from 6.99 million shares to 29.98 million shares, or a 17.8 percent stake.
    HUYA Inc. (NYSE: HUYA) gained 13.1
  • [By Max Byerly]

    These are some of the news headlines that may have impacted Accern Sentiment’s scoring:

    Get AXT alerts:

    Gallium Arsenide Global Market Players by 2023- Sumitomo Electric, AXT and China Crystal Technologies (newspharmaceuticals.com) TheStreet Downgrades AXT (AXTI) to C+ (americanbankingnews.com) Is this stock is Overbought? AXT, Inc. (AXTI) (stockquote.review) What Investors Should Know? AXT, Inc. (AXTI) (mostvolatilestocks.com) Community rallies around valley high school, putting on its first musical in 20 years (yourcentralvalley.com)

    Several analysts have recently issued reports on AXTI shares. BidaskClub upgraded AXT from a “hold” rating to a “buy” rating in a research note on Wednesday, February 14th. Dougherty & Co reiterated a “buy” rating on shares of AXT in a research note on Thursday, February 22nd. B. Riley decreased their price target on AXT from $8.75 to $8.25 and set a “neutral” rating for the company in a research note on Thursday, February 22nd. Zacks Investment Research downgraded AXT from a “buy” rating to a “hold” rating in a research note on Monday, January 1st. Finally, BWS Financial restated a “buy” rating on shares of AXT in a research note on Tuesday, April 17th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and four have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $10.44.

  • [By Lisa Levin] Gainers
    Comstock Holding Companies, Inc. (NASDAQ: CHCI) shares climbed 154.95 percent to close at $5.15 on Thursday. Comstock reported conversion of the majority of its unsecured, short-term debt into non-convertible preferred equity.
    Tyme Technologies, Inc. (NASDAQ: TYME) jumped 33.45 percent to close at $3.87.
    Universal Corporation (NYSE: UVV) gained 29.72 percent to close at $62.85 after reporting fiscal Q4 results.
    Evolus, Inc. (NASDAQ: EOLS) shares rose 22.93 percent to close at $23.80.
    nLIGHT, Inc. (NASDAQ: LASR) jumped 21.52 percent to close at $36.37 following Q1 results.
    Hudson Technologies Inc. (NASDAQ: HDSN) gained 20.28 percent to close at $2.61.
    The Cato Corporation (NYSE: CATO) shares rose 19.57 percent to close at $21.45 after the company posted better-than-expected first-quarter results.
    AXT, Inc. (NASDAQ: AXTI) gained 18.8 percent to close at $7.90.
    Catasys, Inc. (NASDAQ: CATS) rose 16.33 percent to close at $6.41.
    HUYA Inc. (NYSE: HUYA) rose 15.68 percent to close at $23.09 on Thursday.
    Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) climbed 15.11 percent to close at $6.02 on Thursday after gaining 6.30 percent on Wednesday. Baird initiated coverage on Marinus Pharmaceuticals with an Outperform rating.
    Destination Maternity Corporation (NASDAQ: DEST) shares rose 14.48 percent to close at $3.32 after the board announced late Wednesday the election of four activist-backed director nominees. Three women and one man comprise the selected group championed by NGM Capital’s Nathan Miller and Kenosis Capital’s Peter O’Malley. Destination Maternity had advocated for another slate of three men and interim CEO Melissa Payner-Gregor. The new directors are Holly Alden, Marla Ryan, Anne-Charlotte Windal and Christopher Morgan.
    China Rapid Finance Limited (NYSE: XRF) gained 11.53 percent to close at $3.29 after announcing preliminary Q1 results.
    Bilibili Inc.. (NASDAQ: BILI) shares rose 11.33 pe

Top 10 Undervalued Stocks To Watch Right Now: Selective Insurance Group, Inc.(SIGI)

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Selective Insurance Group Inc  (NASDAQ:SIGI)Q4 2018 Earnings Conference CallFeb. 01, 2019, 10:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Ethan Ryder]

    Selective Insurance Group (NASDAQ:SIGI) was downgraded by equities research analysts at BidaskClub from a “hold” rating to a “sell” rating in a research note issued to investors on Wednesday.

  • [By Shane Hupp]

    BidaskClub downgraded shares of Selective Insurance (NASDAQ:SIGI) from a hold rating to a sell rating in a report published on Monday.

    A number of other equities research analysts have also issued reports on SIGI. ValuEngine upgraded shares of Selective Insurance from a hold rating to a buy rating in a report on Friday, February 2nd. Keefe, Bruyette & Woods set a $62.00 price target on shares of Selective Insurance and gave the stock a hold rating in a research note on Monday, February 5th. Zacks Investment Research downgraded shares of Selective Insurance from a buy rating to a hold rating in a report on Wednesday, March 14th. Sandler O’Neill reaffirmed a hold rating and set a $61.00 price objective on shares of Selective Insurance in a report on Friday, April 6th. Finally, Boenning Scattergood reaffirmed a hold rating on shares of Selective Insurance in a report on Thursday, May 3rd. Two investment analysts have rated the stock with a sell rating and five have given a hold rating to the stock. The stock currently has a consensus rating of Hold and an average target price of $62.50.

  • [By Stephan Byrd]

    Baldwin & Lyons Inc Class B (NASDAQ: SIGI) and Selective Insurance Group (NASDAQ:SIGI) are both finance companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, analyst recommendations, profitability, risk and earnings.

  • [By Shane Hupp]

    Aspen Insurance (NASDAQ: SIGI) and Selective Insurance Group (NASDAQ:SIGI) are both mid-cap finance companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations.

Top 10 Undervalued Stocks To Watch Right Now: (SMPQY)

Advisors’ Opinion:

  • [By ]

    I studied the management running the company and found fantastic professionals coming from large institutions like Novartis AG (NYSE:NVS), Sun Pharmaceuticals Industries (OTCPK:SMPQY), AstraZeneca Group plc (NYSE:AZN), or Endo International plc (NASDAQ

Top 10 Gold Stocks To Buy Right Now

adidas (FRA:ADS) received a €222.00 ($258.14) target price from stock analysts at Kepler Capital Markets in a research report issued to clients and investors on Friday. The brokerage presently has a “buy” rating on the stock. Kepler Capital Markets’ price target would indicate a potential upside of 18.75% from the company’s previous close.

Other research analysts have also recently issued reports about the company. Goldman Sachs Group set a €215.00 ($250.00) target price on adidas and gave the stock a “buy” rating in a research report on Wednesday, March 14th. Independent Research set a €193.00 ($224.42) target price on adidas and gave the stock a “neutral” rating in a research report on Wednesday, March 14th. Deutsche Bank set a €205.00 ($238.37) price objective on adidas and gave the company a “neutral” rating in a research report on Thursday, March 15th. Commerzbank set a €236.00 ($274.42) price objective on adidas and gave the company a “buy” rating in a research report on Friday. Finally, equinet set a €211.00 ($245.35) price objective on adidas and gave the company a “buy” rating in a research report on Wednesday, March 14th. Ten equities research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus price target of €213.46 ($248.21).

Top 10 Gold Stocks To Buy Right Now: Peoples Bancorp Inc.(PEBO)

Advisors’ Opinion:

  • [By Joseph Griffin]

    BidaskClub downgraded shares of Peoples Bancorp (NASDAQ:PEBO) from a strong-buy rating to a buy rating in a report released on Friday.

    Several other equities analysts have also recently issued reports on PEBO. Boenning Scattergood reissued a hold rating on shares of Peoples Bancorp in a research note on Wednesday, April 25th. Hovde Group set a $39.00 price objective on shares of Peoples Bancorp and gave the company a hold rating in a research note on Tuesday, April 24th. Zacks Investment Research raised shares of Peoples Bancorp from a hold rating to a buy rating and set a $37.00 price objective on the stock in a research note on Wednesday, January 10th. ValuEngine raised shares of Peoples Bancorp from a hold rating to a buy rating in a research note on Tuesday, April 24th. Finally, Sandler O’Neill reissued a hold rating and issued a $37.00 price objective on shares of Peoples Bancorp in a research note on Tuesday, January 23rd. Five investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Peoples Bancorp has a consensus rating of Hold and a consensus target price of $38.00.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Peoples Bancorp (PEBO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Gold Stocks To Buy Right Now: (SMPQY)

Advisors’ Opinion:

  • [By ]

    I studied the management running the company and found fantastic professionals coming from large institutions like Novartis AG (NYSE:NVS), Sun Pharmaceuticals Industries (OTCPK:SMPQY), AstraZeneca Group plc (NYSE:AZN), or Endo International plc (NASDAQ

Best Medical Stocks To Buy For 2019

When my friend Seth asked me to invest in his new wine store, the decision was easy…   He'd already answered the most important question you must ask before making an investment.   Most investors forget to ask this question. But as I'll explain today, if you know how to answer it, you'll set yourself apart from the crowd…   I got to know Seth while I was in medical school at the University of North Carolina at Chapel Hill and he was the wine buyer for a local grocery store… He was educated as a chef and was working on his Master Sommelier badge. (A "sommelier" or "wine steward" is the wine expert at high-end restaurants. You must pass an exam to throw around the snooty French title, and "master" is the highest level of certification.)   Seth always gave great suggestions for meal and wine pairings and would remember them months later… As a customer, I could tell he cared about me, listened, and gave great advice (a spectacular combination). So when he approached me about backing his shop… I knew he understood wine and had a passion for it.

Best Medical Stocks To Buy For 2019: Jersey Elec.(a)

Advisors’ Opinion:

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Agilent Technologies, Inc. (NYSE: A) to post quarterly earnings at $0.64 per share on revenue of $1.21 billion after the closing bell. Agilent shares rose 0.86 percent to close at $69.45 on Friday.
    Analysts expect Hanwha Q CELLS Co., Ltd. (NASDAQ: HQCL) to report quarterly earnings at $0.14 per share on revenue of $438.40 million before the opening bell. Hanwha Q CELLS shares fell 0.29 percent to close at $6.92 on Friday.
    NiSource Inc. (NYSE: NI) disclosed a 24.96 million share common stock offering via selling holders. NiSource shares rose 0.08 percent to close at $24.93 on Friday.
    Analysts are expecting Vipshop Holdings Limited (NYSE: VIPS) to have earned $0.18 per share on revenue of $3.10 billion in the latest quarter. Vipshop will release earnings after the markets close. Vipshop shares rose 0.20 percent to $15.14 in after-hours trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Tuesday was Agilent Technologies, Inc. (NYSE: A) which traded down about 10% at $62.51. The stocks 52-week range is $55.60 to $75.00. Volume was 14 million compared to the daily average volume of 2.6 million.

  • [By Dan Caplinger]

    Tuesday was a down day for stocks, with the Dow Jones Industrial Average falling early to triple-digit losses and other major benchmarks declining by a similar percentage. The yield on the 10-year Treasury jumped well above the 3% mark, leading to speculation that a sustained upward move for interest rates could start to sap away some of the strength of the nearly decadelong bull market in stocks. Adding to the downward pressure was badly received news from several prominent individual companies. Switch (NYSE:SWCH), Vipshop Holdings (NYSE:VIPS), and Agilent Technologies (NYSE:A) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Stephan Byrd]

    CIBC Asset Management Inc lessened its holdings in Agilent Technologies (NYSE:A) by 4.5% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 29,087 shares of the medical research company’s stock after selling 1,377 shares during the period. CIBC Asset Management Inc’s holdings in Agilent Technologies were worth $1,946,000 as of its most recent SEC filing.

  • [By Taylor Cox]

    Notable Earnings

    Agilent Technologies, Inc (NYSE: A) Q2 after hours

    Investor Events

    Spotify Technology (NYSE: SPOT) IPO quiet period expiration
    IPO/ offering lockup expiration for SendGrid, Inc (NYSE: SEND)
    Herbalife Nutrition Ltd (NYSE: HLF) 2-for-1 stock split goes into effect

    Tuesday
    Economic

  • [By ]

    These include: Adobe Systems Inc. (ADBE) , ADT Inc. (ADT) , Agilent Technologies Inc. (A) , Allergan Plc (AGN) , Anthem Inc. (ANTM) , Apple Inc. (AAPL) , Boston Scientific (BSX) , Cigna Corp. (CI) , Discovery Communications (DISCA) and Dr. Pepper Snapple Group Inc. (DPS) .

Best Medical Stocks To Buy For 2019: Navistar International Corporation(NAV)

Advisors’ Opinion:

  • [By Asit Sharma]

    Navistar International Corporation’s (NYSE:NAV)fiscal second-quarter 2018 results, released earlier this month, revealed that the commercial truck manufacturer is utilizing its capacity to take advantage of favorable economic conditions. Revenue rose nearly 16%, to $2.4 billion, during the last three months, and Navistar posted net profit of $55 million against a loss of $80 million in the prior-year quarter.

  • [By Shane Hupp]

    NavCoin (CURRENCY:NAV) traded up 17.9% against the dollar during the 1-day period ending at 15:00 PM E.T. on May 20th. Over the last week, NavCoin has traded up 19.5% against the dollar. One NavCoin coin can currently be bought for about $1.28 or 0.00015092 BTC on exchanges including Cryptopia, Binance, Bittrex and cfinex. NavCoin has a total market capitalization of $80.73 million and $13.02 million worth of NavCoin was traded on exchanges in the last day.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Navistar International (NAV)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    NavCoin (CURRENCY:NAV) traded up 3.1% against the US dollar during the 24 hour period ending at 12:00 PM ET on May 14th. NavCoin has a market cap of $69.58 million and approximately $924,266.00 worth of NavCoin was traded on exchanges in the last day. Over the last week, NavCoin has traded 12.8% lower against the US dollar. One NavCoin coin can now be bought for $1.11 or 0.00012616 BTC on cryptocurrency exchanges including LiteBit.eu, Upbit, cfinex and Poloniex.

  • [By Paul Ausick]

    While the transition period from one chief executive officer to another has barely gotten started at Volkswagen, some big changes may already be afoot. VW’s commercial-vehicles unit, Volkswagen Truck & Bus, is looking at the possibility of buying more shares in U.S. truck maker Navistar International Corp. (NYSE: NAV) or even acquiring the whole company outright.

  • [By Motley Fool Staff]

    Navistar International Corporation (NYSE:NAV)Q2 2018 Earnings Conference CallJune 5, 2018, 9:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Best Medical Stocks To Buy For 2019: The Hanover Insurance Group, Inc.(THG)

Advisors’ Opinion:

  • [By Max Byerly]

    The Hanover Insurance Group (NYSE:THG) was upgraded by stock analysts at Keefe, Bruyette & Woods from a “market perform” rating to an “outperform” rating in a research report issued on Friday, Marketbeat Ratings reports.

  • [By Logan Wallace]

    Scout Investments Inc. acquired a new position in shares of The Hanover Insurance Group, Inc. (NYSE:THG) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 174,629 shares of the insurance provider’s stock, valued at approximately $20,587,000. Scout Investments Inc. owned about 0.41% of The Hanover Insurance Group at the end of the most recent quarter.

  • [By Joseph Griffin]

    Goelzer Investment Management Inc. reduced its holdings in shares of The Hanover Insurance Group, Inc. (NYSE:THG) by 3.7% during the 1st quarter, HoldingsChannel reports. The fund owned 40,309 shares of the insurance provider’s stock after selling 1,563 shares during the period. Goelzer Investment Management Inc.’s holdings in The Hanover Insurance Group were worth $4,752,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    Teacher Retirement System of Texas cut its holdings in The Hanover Insurance Group, Inc. (NYSE:THG) by 36.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,373 shares of the insurance provider’s stock after selling 5,283 shares during the quarter. Teacher Retirement System of Texas’ holdings in The Hanover Insurance Group were worth $1,105,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Best Medical Stocks To Buy For 2019: Brainstorm Cell Therapeutics Inc.(BCLI)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Hanwha Q CELLS Co., Ltd. (NASDAQ: HQCL) is estimated to report quarterly earnings at $0.14 per share on revenue of $438.40 million.
    Remark Holdings, Inc. (NASDAQ: MARK) is projected to report quarterly loss at $0.35 per share on revenue of $19.45 million.
    Athenex, Inc. (NYSE: ATNX) is expected to report quarterly loss at $0.07 per share on revenue of $35.14 million.
    Mazor Robotics Ltd. (NASDAQ: MZOR) is estimated to report quarterly loss at $0.08 per share on revenue of $15.14 million.
    Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) is projected to report a quarterly loss at $0.14 per share.
    SuperCom Ltd. (NASDAQ: SPCB) is expected to report quarterly earnings at $0.08 per share on revenue of $9.50 million.
    Lonestar Resources US Inc. (NASDAQ: LONE) is projected to report quarterly loss at $0.04 per share on revenue of $30.68 million.
    Nine Energy Service, Inc. (NASDAQ: NINE) is estimated to report quarterly earnings at $0.1 per share on revenue of $165.76 million.
    VEON Ltd. (NASDAQ: VEON) is projected to report quarterly earnings at $0.05 per share on revenue of $212.00 million.

     

  • [By Shane Hupp]

    These are some of the media headlines that may have impacted Accern Sentiment Analysis’s analysis:

    Get Brainstorm Cell Therapeutics alerts:

    Brainstorm Cell Therapeutics (BCLI) Issues Quarterly Earnings Results, Beats Expectations By $0.20 EPS (americanbankingnews.com) BrainStorm Announces First Quarter 2018 Financial Results and Provides Corporate and Clinical Highlights (finance.yahoo.com) What analyst predict for Brainstorm Cell Therapeutics NASDAQ:BCLI ? (stockmarketdaily.co) Global Autologous Cell Therapy Market 2022: Market Size, Shares, Revenue, Production, Consumption (thetechnicalprogress.com) Hot Stocks to Observe: Forward Industries, Inc. (NASDAQ:FORD), Nordic American Tankers Limited (NYSE:NAT … (journalfinance.net)

    Shares of Brainstorm Cell Therapeutics traded up $0.12, hitting $3.76, during trading hours on Monday, according to MarketBeat. 1,552 shares of the stock were exchanged, compared to its average volume of 63,674. The company has a market cap of $69.42 million, a P/E ratio of -14.46 and a beta of 1.86. Brainstorm Cell Therapeutics has a one year low of $3.70 and a one year high of $3.85.

  • [By Lisa Levin] Gainers
    Axovant Sciences Ltd. (NASDAQ: AXON) shares rose 23.7 percent to $1.49. Axovant announced strengthening of management team and completion of organization restructuring which "enhanced capabilities in research and business development" and reduced internal headcount by 43 percent.
    Mammoth Energy Services, Inc. (NASDAQ: TUSK) shares jumped 19.8 percent to $37.3148. Mammoth Energy’s subsidiary Cobra signed a new $900 million contract to finish the restoration of critical electrical services and support the initial phase of reconstruction of the electrical utility system in Puerto Rico.
    Acorn International, Inc. (NYSE: ATV) shares gained 19 percent to $34.0201. Acorn shares rose Friday after the company declared a special one-time cash dividend of $14.97 per ADS.
    DHI Group, Inc. (NYSE: DHX) shares surged 19 percent to $2.20.
    My Size, Inc. (NASDAQ: MYSZ) climbed 16.8 percent to $1.18 after the company received a Notice of Allowance from the USPTO for measurement technology patent.
    Global Eagle Entertainment Inc. (NASDAQ: ENT) gained 16.6 percent to $2.32.
    Leju Holdings Limited (NYSE: LEJU) gained 16.5 percent to $1.34 following Q1 beat.
    Evolus, Inc. (NASDAQ: EOLS) shares surged 16.5 percent to $26.1499. Evolus named Lauren Silvernail as Chief Financial Officer and Executive Vice President, Corporate Development.
    Jupai Holdings Limited (NYSE: JP) shares gained 15 percent to $26.29 after reporting Q1 results.
    Momo Inc. (NASDAQ: MOMO) shares gained 15 percent to $44.7702 after the company reported better-than-expected results for its first quarter and issued strong sales forecast for the second quarter.
    Windstream Holdings, Inc. (NASDAQ: WIN) rose 15 percent to $7.075.
    China Advanced Construction Materials Group, Inc. (NASDAQ: CADC) gained 14.4 percent to $2.746.
    American Woodmark Corporation (NASDAQ: AMWD) climbed 14.2 percent to $101.10 after the company reported upbeat Q4 results.
    Savara Inc. (NAS
  • [By Logan Wallace]

    Maxim Group set a $9.00 target price on Brainstorm Cell Therapeutics (NASDAQ:BCLI) in a research note issued to investors on Monday morning. The brokerage currently has a buy rating on the biotechnology company’s stock.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Jounce Therapeutics, Inc. (NASDAQ: JNCE) fell 32.5 percent to $11.92 in pre-market trading. Jounce Therapeutics reported that data from ongoing ICONIC trial of JTX-2011 will be presented at the ASCO.
    Acxiom Corporation (NASDAQ: ACXM) fell 10.7 percent to $24.60 in pre-market trading. Acxiom reported stronger-than-expected results for its fourth quarter, but issued weak FY19 guidance.
    American Public Education, Inc. (NASDAQ: APEI) shares fell 10.7 percent to $35 in pre-market trading.
    Enduro Royalty Trust (NYSE: NDRO) shares fell 8.5 percent to $3.25 in pre-market trading after tumbling 10.76 percent on Wednesday.
    NetEase, Inc. (NASDAQ: NTES) fell 8.3 percent to $244.00 in pre-market trading after reporting Q1 results.
    Aircastle Limited (NYSE: AYR) fell 7.2 percent to $21.30 in pre-market trading after announcing 7.9 million secondary offering of common shares.
    Boxlight Corporation (NASDAQ: BOXL) shares fell 5.6 percent to $9.29 in pre-market trading after rising 2.29percent on Wednesday.
    Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) shares fell 5.3 percent to $3.93 in pre-market trading after rising 5.60 percent on Wednesday.
    Cisco Systems, Inc. (NASDAQ: CSCO) fell 4 percent to $43.40 in pre-market trading. Cisco reported better-than-expected results for its third quarter. The company sees fourth quarter earnings in the range of 68 cents-70 cents with sales growth of 4-6 percent.
    Jack in the Box Inc. (NASDAQ: JACK) fell 3.2 percent to $88.45 in pre-market trading after the company reported downbeat results for its second quarter. Comps were down 0.1 percent in the quarter. The company sees third-quarter comps coming in flat to up 1 percent.
    Children's Place, Inc. (

Best Medical Stocks To Buy For 2019: (SMPQY)

Advisors’ Opinion:

  • [By ]

    I studied the management running the company and found fantastic professionals coming from large institutions like Novartis AG (NYSE:NVS), Sun Pharmaceuticals Industries (OTCPK:SMPQY), AstraZeneca Group plc (NYSE:AZN), or Endo International plc (NASDAQ

Top 10 Stocks To Own For 2018

Wall Street analysts tend to be a bullish lot, and few have been as bullish as FundStrat’s Thomas Lee, who’s been accused of being a perma-bull. But just as his colleagues seem to be embracing another year of gains, Lee has decided to dial back the optimism. In his 2017 outlook released today, Lee wrote that he expects that S&P 500 to finish the year at 2,275, down a few points from a recent 2,278.72, and could drop as low as 2,150 during the first half of the year. He lists the downside risks:

Bloomberg News

A sloppy White House organization creates confusion on US policy, particularly as tweets become policy. Washington does not pass infrastructure stimulus. Tax reform multiplier is smaller than market is
expecting. Trump fires JanetFed becomes fall guy for Trump when equity markets get volatile. Fed tightens excessively. USD soars. Europe migrant issues deteriorates and crexit worsens. Former President Obama becomes a vocal critic.

Wow. Who would have thunk it?

Top 10 Stocks To Own For 2018: Reinsurance Group of America, Incorporated(RGA)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    Morgan Stanley downgraded Chipotle (NYSE: CMG) to Equal-Weight.
    UBS downgraded AMC Networks (NASDAQ: AMCX) to Sell.
    Citi upgraded Sealed Air (NYSE: SEE) to Buy.
    Goldman Sachs upgraded Reinsurance Group (NYSE: RGA) to Buy.

  • [By David Sterman]

    My favorite insurers: AIG (NYSE: AIG) (which I discussed a few months ago), Protective Life (NYSE: PL) and Reinsurance Group of America (NYSE: RGA).

Top 10 Stocks To Own For 2018: Aimia Inc. (GAPFF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Aimia (OTCPK:GAPFF) (TSX: AIM, AIM.PR.A, AIM.PR.B, AIM.PR.C)

    As some background, we are intimately familiar with Aeroplan and Air Canada (OTCQX:ACDVF) not just as investors but as extraordinarily heavy consumers. As both an Air Canada top tier elite and Aeroplan top tier member I generate well in excess of 1.5 million Aeroplan miles annually, half from flying Air Canada and its partners and the other half from spending. As consumers we were concerned with Air Canada’s decision (though we expect more details to come out that will alleviate these concerns) but as investors we understand that the fundamental business model of mileage programs are incredibly attractive and that Aimia presents an incredibly rare and lucrative investment opportunity for the investor discerning enough to dig into the company.

Top 10 Stocks To Own For 2018: Intuit Inc.(INTU)

Advisors’ Opinion:

  • [By Asit Sharma]

    It’s tax season — the four months when tax and small-business software providerIntuit Inc.(NASDAQ:INTU) makes most of its profit for the year. On Thursday, Intuit filed its fiscal second-quarter 2017 earnings report and issued a progress report on its tax business so far this year.Tax volumes are well off last year’s pace: Let’s review the details, as well as management’s interpretation, after a look at the headline numbers.

  • [By Alex Jordon]

    A variety of acquisitions ramps up Oracle’s presence in cloud computing, like deals with RightNow, Taleo, and Eloqua. The annual run-rate of their cloud business is already over $1 billion, larger than Workday (WDAY) and SAP (SAP) combined. New customers include British Telecom (BT), BMC Software (BMC), Siemens (SI), Yahoo (YHOO), and Intuit (INTU).

  • [By Demitrios Kalogeropoulos]

    As for individual stocks, Intuit (NASDAQ:INTU) and Tiffany (NYSE:TIF) saw heavy trading following the companies’ quarterly earnings announcements.

    Image source: Getty Images.

Top 10 Stocks To Own For 2018: Tetra Technologies, Inc.(TTI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Wednesday afternoon, the energy sector proved to be a source of strength for the market. Leading the sector was strength from TETRA Technologies, Inc. (NYSE: TTI) and Abraxas Petroleum Corp. (NASDAQ: AXAS).

  • [By Lisa Levin]

    Energy sector was the top gainer in the US market on Wednesday. Top gainers in the sector included TETRA Technologies, Inc. (NYSE: TTI), CARBO Ceramics Inc. (NYSE: CRR), and Atwood Oceanics, Inc. (NYSE: ATW).

Top 10 Stocks To Own For 2018: MBIA, Inc.(MBI)

Advisors’ Opinion:

  • [By Dan Caplinger]

    But some stocks managed to buck the trend and give investors more upbeat outlooks for their prospects. SandRidge Energy (NYSE: SD), MBIA (NYSE:MBI), and LivePerson (NASDAQ:LPSN) were among the best performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.

Top 10 Stocks To Own For 2018: Flagstar Bancorp, Inc.(FBC)

Advisors’ Opinion:

  • [By Dustin Blitchok]

    When Alessandro DiNello was named CEO of Flagstar Bancorp Inc (NYSE: FBC) in 2013, the bank was on a financial precipice.

    The bank’s business was almost entirely mortgages. As the industry unraveled nationally, Flagstar accepted $267 million in TARP money in 2009 — as well as private equity financing — to maintain solvency.

Top 10 Stocks To Own For 2018: NCI Building Systems, Inc.(NCS)

Advisors’ Opinion:

  • [By Monica Gerson]

    NCI Building Systems Inc (NYSE: NCS) posted upbeat results for its second quarter on Tuesday. NCI Building Systems shares rose 1.24 percent to $16.30 in the after-hours trading session.

  • [By Scott Rubin]

    Equity gainers on the day included Chico's FAS, Inc. (NYSE: CHS), which surged more than 12 percent on the day, and Himax Technologies (NASDAQ: HIMX), which climbed almost 9 percent in the wake of an afternoon rally. Losers included NCI Building Systems Inc. (NYSE: NCS), which fell 15 percent after earnings, and H&R Block inc (NYSE: HRB), which fell almost 11 percent on the day after its Q1 results.

  • [By Lisa Levin]

    On Thursday, the industrial sector proved to be a source of strength for the market. Leading the sector was strength from Envirostar Inc (NYSE: EVI) and NCI Building Systems Inc (NYSE: NCS).

Top 10 Stocks To Own For 2018: Alder BioPharmaceuticals, Inc.(ALDR)

Advisors’ Opinion:

  • [By Paul Ausick]

    Alder Biopharmaceuticals Inc. (NASDAQ: ALDR) posted a new 52-week low of $13.50on Tuesday, down nearly 28% compared with Monday’s closing price of $18.70. The stock’s 52-week high is $36.48. Volume totaled more than 12 million shares, about 12 times the daily average of around 720,000. The company reported that its migraine treatment reported a positive result, but investors were not impressed.

Top 10 Stocks To Own For 2018: Kinross Gold Corporation(KGC)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Given revised commodity deck forecasts (particularly for Steel and Gold) and improved Balance Sheet health (Steels, Precious and Industrials Metals) we are upgrading our ratings on several stocks in our coverage. We generally favor companies that have already initiated specific self-help, have low-cost assets and are less exposed to China supply and demand dynamics. In Steels, we have increased our rating from Hold to Buy on Nucor (NUE) and from Sell to Hold on US Steel. We have also upgraded Kinross Gold (KGC) to a Hold on valuation…On higher-than-peer valuations, we reiterate Sell-rated Coeur Mining (CDE), Franco-Nevada (FNV), Goldcorp (GG), Teck Resources (TCK) and highly leveraged AK Steel given preference to issue further equity if possible.

  • [By Wayne Duggan]

    Citi also placed Neutral ratings on Goldcorp Inc. (USA) (NYSE: GG), Kinross Gold Corporation (USA) (NYSE: KGC) and Silver Standard Resources Inc. (USA) (NASDAQ: SSRI).

  • [By Monica Gerson]

    Kinross Gold Corporation (USA) (NYSE: KGC) is projected to post a quarterly loss at $0.01 per share on revenue of $808.09 million.

    Crocs, Inc. (NASDAQ: CROX) is expected to report its quarterly earnings at $0.05 per share on revenue of $265.90 million.

  • [By Lee Jackson]

    Kinross Gold Corp. (NYSE: KGC) may be the stock that give investors the most amount of leverage on a gold rebound. Management reduced the company’s annual capital expenditures forecast to $1.45 billion from $1.6 billion, saving $180 million from its cost restructuring initiatives. Cancellation of its upcoming semiannual dividend payment to its shareholders will save $182 million per year. Kinross expects to produce gold at a cost of $1,000 to $1,200 an ounce this year. The Merrill Lynch target is $7.00, and the consensus target is $6.55. The dividend, which soon will be cancelled, has a yield of 2.9%.

Top 10 Stocks To Own For 2018: (SMPQY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    The majority owner is Sun Pharma (OTC:SMPQY) (the largest drug business in India). There have been a number of articles that have outlined Sun Pharma and its quest for Taro, but it makes a lot of sense for Sun to want to own all – and not just the majority – of Taro. One big reason is that owning all of Taro means that any investments that Sun makes with Taros $1.2 billion cash hoard will not be diluted by the presence of minority shareholders. Another reason that Sun likely wants Taro is simply because it is very cheap right now. Sun is run by its founder and majority shareholder, Dilip Shanghvi, who is sort of a pharmaceutical value investor who has opportunistically made acquisitions and investments over time, building his firm starting with a loan of $200 in the early 1980s to the multi-billion business it is today.

  • [By SEEKINGALPHA.COM]

    We believe that two main risks currently exist. First, a few days ago, U.S. Department of Justice filed charges in generic drug price-fixing probe. The U.S. Department of Justice accused two former generic pharmaceutical executives of colluding with other generic manufacturers to fix prices – the first criminal charges stemming from a two-year investigation. Companies in the congressional probe have since publicly disclosed that they have received subpoenas, including Mylan NV (NASDAQ:MYL), Allergan (NYSE:AGN), which later sold its generics business to Teva (NASDAQ:TEVA), Lannett (NYSEMKT:LCI), Impax Laboratories (NASDAQ:IPXL), Endo International (NASDAQ